Chinese Biotechs Ascend Deal-Making By Partnering Up Claudin 18.2 Agents

evolve deal making
Six Chinese biotechs have inked deals with major multinationals on the Claudin 18.2 target so far • Source: Shutterstock

More from China

More from Focus On Asia